Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...

Antitotal IgG as secondary antibody. ¶ Anti-IgG1, IgG2 and IgG3 as secondary antibody. # 17 additional healthy controls tested negative. IIF: Immunofluorescence; PBC: Primary biliary cirrhosis.

Individuals with primary biliary cholangitis and diabetes may experience worse outcomes, such as progression to end-stage liver disease.

Primary biliary cholangitis (PBC) may be rare, but its impact on women can be profound, leaving too many undiagnosed for ...

Opens in a new tab or window Once clinical suspicion has been established for primary biliary cholangitis (PBC ... so most patients already presented with cirrhosis and jaundice," said David ...

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...

The analysis revealed that 81% of individuals treated with Livdelzi achieved a composite biochemical response.

On Friday, Gilead Sciences, Inc. (NASDAQ:GILD) revealed data from a two-and-a-half-year interim analysis from the ongoing ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

Primary biliary cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, resulting in chronic cholestasis, portal inflammation ...